Amyloid Fibril Toxicity in Alzheimer's Disease and Diabetesa

Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides

1990 • 1,975 citations

Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

1993 • 1,422 citations

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

1994 • 1,313 citations

Neurotoxicity of a Fragment of the Amyloid Precursor Associated with Alzheimer's Disease

1989 • 904 citations

In vitro aging of ß-amyloid protein causes peptide aggregation and neurotoxicity

1991 • 833 citations

Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus

1994 • 815 citations

Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF

1993 • 383 citations

Methodological variables in the assessment of beta amyloid neurotoxicity

1992 • 208 citations

Islet Amyloid, Islet-Amyloid Polypeptide, and Diabetes Mellitus

1989 • 203 citations

Neurotoxicity of Human Amylin in Rat Primary Hippocampal Cultures: Similarity to Alzheimer's Disease Amyloid‐β Neurotoxicity

1993 • 122 citations

β-Amyloid from Alzheimer disease brains inhibits sprouting and survival of sympathetic neurons

1991 • 103 citations

Commentary and perspective on studies of beta amyloid neurotoxicity

1992 • 40 citations